| Title: |
Evaluation of three physiologically based pharmacokinetic (PBPK) modeling tools for emergency risk assessment after acute dichloromethane exposure. |
| Authors: |
Boerleider, R.Z.1,2, Olie, J.D.N.1,3, van Eijkeren, J.C.H.4, Bos, P.M.J.4, Hof, B.G.H.1,5, de Vries, I.1, Bessems, J.G.M.4, Meulenbelt, J.1,2,6, Hunault, C.C.1 C.Hunault@umcutrecht.nl |
| Source: |
Toxicology Letters. Jan2015, Vol. 232 Issue 1, p21-27. 7p. |
| Subject Terms: |
*PHARMACOKINETICS, *BIOLOGICAL models, *RISK assessment, *DICHLOROMETHANE, *PHYSIOLOGICAL effects of chemicals, *GENERIC drugs, *CARBOXYHEMOGLOBIN |
| Abstract: |
Introduction Physiologically based pharmacokinetic (PBPK) models may be useful in emergency risk assessment, after acute exposure to chemicals, such as dichloromethane (DCM). We evaluated the applicability of three PBPK models for human risk assessment following a single exposure to DCM: one model is specifically developed for DCM (Bos) and the two others are semi-generic ones (Mumtaz and Jongeneelen). Materials and methods We assessed the accuracy of the models’ predictions by simulating exposure data from a previous healthy volunteer study, in which six subjects had been exposed to DCM for 1 h. The time-course of both the blood DCM concentration and percentage of carboxyhemoglobin (HbCO) were simulated. Results With all models, the shape of the simulated time course resembled the shape of the experimental data. For the end of the exposure, the predicted DCM blood concentration ranged between 1.52–4.19 mg/L with the Bos model, 1.42–4.04 mg/L with the Mumtaz model, and 1.81–4.31 mg/L with the Jongeneelen model compared to 0.27–5.44 mg/L in the experimental data. % HbCO could be predicted only with the Bos model. The maximum predicted % HbCO ranged between 3.1 and 4.2% compared to 0.4–2.3% in the experimental data. The % HbCO predictions were more in line with the experimental data after adjustment of the Bos model for the endogenous HbCO levels. Conclusions The Bos Mumtaz and Jongeneelen PBPK models were able to simulate experimental DCM blood concentrations reasonably well. The Bos model appears to be useful for calculating HbCO concentrations in emergency risk assessment. [ABSTRACT FROM AUTHOR] |
|
Copyright of Toxicology Letters is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Academic Search Complete |
